Justin C. Moser, MD

Associate Clinical Investigator, Melanoma and Cutaneous Oncology Specialist
HonorHealth Research and Innovation Institute
Scottsdale, Arizona, United States

Presentation(s):

• Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA

  Friday, November 18, 2022
  4:15 PM – 4:23 PM